OrthoSpin was granted FDA 510(k) clearance to market a next-generation robotic digitally-enabled external fixation system.
The OrthoSpin G2 system is approved in Israel as well, and can be used with the DePuy Synthes MAXFRAME™ Multi-Axial Correction System. Parent company Johson & Johnson led an investment round of $3 million for OrthoSpin’s smart robotic external fixation system in 2018.
The company has completed initial clinical cases in the U.S. and Israel with the OrthoSpin Generation 1 system, which makes pre-programmed adjustments automatically without the need for patient involvement. Integrated software allows physicians to chart patient progress and immediately adjust treatment programs. The second-generation system is more user friendly, covers all strut range sizes and is 20% lighter than the original.
Future applications and features may include the ability to follow and modify treatment plans via smart phones, and cloud-based AI algorithms treatment plans based on computerized historical data.
“We are very excited to launch the Generation 2 OrthoSpin system,” said Dr. Assaf Dekel, Active Chairman of OrthoSpin. “We believe that robotic automation will revolutionize the hexapod bone deformity market and we are proud to play a part in this transformation.”
OrthoSpin was granted FDA 510(k) clearance to market a next-generation robotic digitally-enabled external fixation system.
The OrthoSpin G2 system is approved in Israel as well, and can be used with the DePuy Synthes MAXFRAME™ Multi-Axial Correction System. Parent company Johson & Johnson led an investment round of $3 million for...
OrthoSpin was granted FDA 510(k) clearance to market a next-generation robotic digitally-enabled external fixation system.
The OrthoSpin G2 system is approved in Israel as well, and can be used with the DePuy Synthes MAXFRAME™ Multi-Axial Correction System. Parent company Johson & Johnson led an investment round of $3 million for OrthoSpin’s smart robotic external fixation system in 2018.
The company has completed initial clinical cases in the U.S. and Israel with the OrthoSpin Generation 1 system, which makes pre-programmed adjustments automatically without the need for patient involvement. Integrated software allows physicians to chart patient progress and immediately adjust treatment programs. The second-generation system is more user friendly, covers all strut range sizes and is 20% lighter than the original.
Future applications and features may include the ability to follow and modify treatment plans via smart phones, and cloud-based AI algorithms treatment plans based on computerized historical data.
“We are very excited to launch the Generation 2 OrthoSpin system,” said Dr. Assaf Dekel, Active Chairman of OrthoSpin. “We believe that robotic automation will revolutionize the hexapod bone deformity market and we are proud to play a part in this transformation.”
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
